Slayback Pharma
Latest round
- Series B
Last raised
- Jan 2020
Total raised
- $85M
Investors
- 2
About Slayback Pharma
Slayback Pharma, LLC specializes in pharmaceutical development and has been operational since its founding in 2011 in Princeton, US. The company was acquired by Azurity Pharmaceuticals from KKR and Everstone Capital Partners in September 2023, enabling further innovation.Slayback Pharma provides a diverse range of pharmaceutical products designed for niche patient populations. The company’s offerings include over 30 marketed brands across therapeutic areas such as Allergy, Oncology, and Respiratory. Notable products feature XIFYRM™ (meloxicam injection), an FDA-approved NSAID for managing moderate-to-severe pain with a once-daily IV dosing regimen.Slayback Pharma generates revenue through direct sales of its pharmaceutical products and partnerships with healthcare providers.The acquisition by Azurity Pharmaceuticals is set to facilitate the launch of multiple innovative drug products.
Who invested in Slayback Pharma
2 investors across 2 rounds
See all investors in Slayback Pharma
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Slayback Pharma
Who invested in Slayback Pharma?
Slayback Pharma has 2 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Slayback Pharma raised?
Slayback Pharma has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Slayback Pharma last raise money?
Slayback Pharma's most recent round on record is a Series B, in Jan 2020.
What does Slayback Pharma do?
Slayback Pharma, LLC specializes in pharmaceutical development and has been operational since its founding in 2011 in Princeton, US.
Where is Slayback Pharma headquartered?
Slayback Pharma is headquartered in Princeton, US.
Which VCs invest in companies like Slayback Pharma?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back pharmaceuticals companies at Slayback Pharma's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series B
Raising like Slayback Pharma? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.